Clinical Trial Update: Effects of Dapagliflozin on Inflammatory Factorslevel and Prognosis in Type 2 Diabetes With Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 study assessing the effects of dapagliflozin on inflammatory markers and prognosis in patients with type 2 diabetes after acute myocardial infarction; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Qingdao Central Hospital | Conditions: Myocardial Infarction, Diabete Type 2 | Phase 4 | Status: COMPLETED